Device Neuro Pain (Includes Interventional)

Activos 10 Bone Cement

Payments companies reported to CMS as associated with Activos 10 Bone Cement. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$11Kassociated payments (2023-2025)
158clinicians with associated payments
1company reporting

By year

2023 $5,008
2024 $4,013
2025 $1,662

Payments reported as associated with Activos 10 Bone Cement, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Pain Medicine (Anesthesiology) $2,798
Family $998
Interventional Pain Medicine $983
Physical Medicine & Rehabilitation $805
Neurological Surgery $788
Diagnostic Radiology $730

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Activos 10 Bone Cement

These are the largest totals companies reported as associated with Activos 10 Bone Cement. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Binit Shah Huntersville, NC Pain Medicine (Anesthesiology) $615.00
Daniel Bintrim Winston Salem, NC Pain Medicine (Anesthesiology) $615.00
Carlos Viesca El Paso, TX Interventional Pain Medicine $407.75
Matthew Eagleson Saginaw, MI Pain Medicine (Anesthesiology) $358.27
Caleb Ortega Saginaw, MI Pain Medicine (Anesthesiology) $316.58
Brian Keogh Greenville, NC Pain Medicine (Physical Medicine & Rehabilitation) $245.33
Laura Fayad Baltimore, MD Diagnostic Radiology $208.65
Douglas Beall Edmond, OK Diagnostic Radiology $208.63
Karma Williams Jacksonville, NC Family $202.36
Juan Firnhaber-Burgos Greenville, NC Pain Medicine (Anesthesiology) $202.34

Prescribed Activos 10 Bone Cement?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.